Fundoscopy can detect diabetic retinopathy. The exam involves a bright light shined into the eye, allowing an eye doctor to see any potential issues happening in the back of the eye. Share on ...

Zenkuda demonstrated superiority over sham in patients with diabetic retinopathy in the phase 3 GLOW2 study, according to a ...

Survival models using EHR data predicted progression from NPDR or DME to PDR in type 2 diabetes patients. Key risk factors for progression included age, race, NPDR severity, and diabetic nephropathy.

Swelling, leaking blood vessels, or atypical growths can occur in your retina when you develop diabetic retinopathy. Recognizing specific changes can help your doctor diagnose your eye condition ...

Please provide your email address to receive an email when new articles are posted on . OCT angiography can measure changes in the foveal avascular zone (FAZ) area. FAZ area deteriorated in stable ...

Cataract surgery was associated with an increased risk of worsening diabetic retinopathy in adults with type 2 diabetes. Diabetes is a risk factor for complications due to cataract surgery. Patients ...

The preparation of evidence-based guidelines is highlighted by the WHO as an important component in the concerted effort to eliminate avoidable blindness. [149] This review has highlighted ...

Positive topline results from the phase 3 GLOW2 trial suggest that tarcocimab tedromer (Zenkuda), an investigational anti–vascular endothelial growth factor (VEGF) biologic, may offer durable disease ...

Diabetic retinopathy is an irreversible condition that damages the eye’s retina and can lead to vision loss. It occurs as a potential complication of diabetes from prolonged periods of hyperglycemia.

AAO: American Academy of Ophthalmology; CDA: Canadian Diabetes Association; DM: Diabetes mellitus; ISPAD: International Society for Pediatric and Adolescent Diabetes; NHMRC: National Health and ...